Fabio Tramuto

Fabio Tramuto

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2011 in Environmental Health
Verified
Journal Article
Open access
PDF file
FTFabio Tramuto
Fabio Tramuto
RCRosanna Cusimano
Rosanna Cusimano
GCGiuseppe Cerame
Giuseppe Cerame
MVMarcello Vultaggio
Marcello Vultaggio
GCGiuseppe Calamusa
Giuseppe Calamusa
FVFrancesco Vitale
Francesco Vitale
Air pollution from vehicular traffic has been associated with respiratory diseases. In Palermo, the largest metropolitan area in Sicily, urban air pollution is mainly addressed to traffic-related pollution because of lack of industrial settlements, and the presence of a temperate climate that contribute to the limited use of domestic heating plants. This study aimed to investigate the association between traffic-related air pollution and emergency room admissions for acute respiratory symptoms.

19 August 2022 in Journal of Infection
Verified
Journal Article
Closed access
Santi NolascoSanti Nolasco
Santi Nolasco
FVFrancesco Vitale
Francesco Vitale
AGAlessandro Geremia
Alessandro Geremia
FTFabio Tramuto
Fabio Tramuto
CMCarmelo Massimo Maida
Carmelo Massimo Maida
AMArturo Montineri
Arturo Montineri

22 February 2008 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
FVFrancesco Vitale
Francesco Vitale
FTFabio Tramuto
Fabio Tramuto
AOAmbrogio Orlando
Ambrogio Orlando
GVGiovanni Vizzini
Giovanni Vizzini
VMValentina Meli
Valentina Meli
NRNino Romano
Nino Romano

1 October 2011 in Vaccine
Verified
Journal Article
Closed access
EAEmanuele Amodio
Emanuele Amodio
FTFabio Tramuto
Fabio Tramuto
GMGuido Maringhini
Guido Maringhini
RARosario Asciutto
Rosario Asciutto
AFAlberto Firenze
Alberto Firenze
GCGiuseppe Calamusa
Giuseppe Calamusa

27 February 2020 in Healthcare
Verified
Journal Article
Open access
PDF file
Emanuele AmodioEmanuele Amodio
Emanuele Amodio
FVFrancesco Vitale
Francesco Vitale
LCLivia Cimino
Livia Cimino
Alessandra CasuccioAlessandra Casuccio
Alessandra Casuccio
FTFabio Tramuto
Fabio Tramuto
On 31 December, 2019, a cluster of 27 pneumonia cases of unknown etiology was reported by Chinese health authorities in Wuhan City (China)

15 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Emanuele AmodioEmanuele Amodio
Emanuele Amodio
Rosaria Maria PipitoneRosaria Maria Pipitone
Rosaria Maria Pipitone
Stefania GrimaudoStefania Grimaudo
Stefania Grimaudo
Palmira ImmordinoPalmira Immordino
Palmira Immordino
CMCarmelo Massimo Maida
Carmelo Massimo Maida
Alessandra CasuccioAlessandra Casuccio
Alessandra Casuccio
The course of SARS-CoV-2 infection ranges from asymptomatic to a multiorgan disease. In this observational study, we investigated SARS-CoV-2 infected subjects with defined outcomes, evaluating the relationship between viral load and single nucleotide polymorphisms of genes codifying for IFNλs (interferon). The study enrolled 381 patients with laboratory-confirmed SARS-CoV-2 infection. For each patient, a standardized form was filled including sociodemographic variables and clinical outcomes. The host’s gene polymorphisms (IFNL3 rs1297860 C/T and INFL4 rs368234815 TT/ΔG) and RtReal-Time PCR cycle threshold (PCR Ct) value on SARS-CoV-2 were assessed on nasal, pharyngeal or nasopharyngeal swabs. Higher viral loads were found in patients aged > 74 years and homozygous mutant polymorphisms DG in IFNL4 (adj-OR = 1.16, 95% CI = 1.01–1.34 and adj-OR = 1.24, 95% CI = 1.09–1.40, respectively). After adjusting for age and sex, a statistically significantly lower risk of hospitalization was observed in subjects with higher RtReal-Time PCR cycle threshold values (adj-OR = 0.95, 95% CI = 0.91, 0.99; p = 0.028). Our data support the correlation between SARS-CoV-2 load and disease severity, and suggest that IFNλ polymorphisms could affect the ability of the host to modulate viral infection without a clear impact on the outcome of COVID-19.